PMID: 15365404Sep 15, 2004Paper

Irritable bowel syndrome medications side effects survey

Journal of Clinical Gastroenterology
A J Lembo

Abstract

This study was conducted to determine the frequency and severity of side effects (SEs) experienced during treatment with standard medications used to treat patients with irritable bowel syndrome (IBS) with constipation (IBS-C). In January of 2002, 668 subjects responded to a survey addressed to an online panel of 25,000 physician-diagnosed IBS sufferers. Of the survey respondents, 504 had constipation as a predominant bowel habit (median age 45 years, and 88% were women). Respondents answered questions about the therapies they used to relieve their IBS symptoms and about any SEs they experienced while taking these therapies; they were also asked to rate their satisfaction with their current/past medications. To gauge IBS impact, respondents were also asked about the number of times they either visited or called their health-care provider about their IBS symptoms and approximately how many days of work or school they missed because of their IBS symptoms. Subjects reported having tried an average of 3.9 +/- 3.3 medications for their IBS-C symptoms with virtually all subjects (99%) having tried at least 1 medication. Subjects reported an average of 3.3 +/- 2.7 SEs. Nearly three quarters reported discontinuing treatment because of ...Continue Reading

References

Sep 1, 1993·Journal of Advanced Nursing·C P Dancey, S Backhouse
Apr 29, 1999·Archives of Internal Medicine·X H HuM L Berger
May 11, 1999·The American Journal of Gastroenterology·T LemboE A Mayer
Jan 19, 2000·The American Journal of Gastroenterology·N A KoloskiP M Boyce
Sep 13, 2000·Gastroenterology·I M GralnekE A Mayer
Nov 3, 2001·European Journal of Gastroenterology & Hepatology·D B Silk
Nov 28, 2001·The American Journal of Gastroenterology·R L LevyA D Feld
Aug 20, 2002·Journal of Clinical Gastroenterology·J G Rosemore, Brian E Lacy
Oct 24, 2002·Gastroenterology Nursing : the Official Journal of the Society of Gastroenterology Nurses and Associates·Margaret HeitkemperLin Cheng
Feb 13, 2003·Archives of Internal Medicine·Jennifer A SpanierMichael P Jones
Jul 16, 2003·Gastroenterology Clinics of North America·Samuel C Somers, Anthony Lembo
Aug 10, 2004·Journal of Managed Care Pharmacy : JMCP·Darrell Hulisz

❮ Previous
Next ❯

Citations

May 4, 2012·International Journal of Clinical Pharmacy·Chong-Han KuaKok-Ann Gwee
Dec 21, 2007·Digestive Diseases and Sciences·Pierre PoitrasMickael Bouin
Jun 23, 2009·Journal of the Chinese Medical Association : JCMA·Full-Young Chang, Ching-Liang Lu
Jul 18, 2006·Alimentary Pharmacology & Therapeutics·J TackG Fisher
Apr 18, 2008·Neurogastroenterology and Motility : the Official Journal of the European Gastrointestinal Motility Society·L Chang
Oct 4, 2007·Journal of the American Geriatrics Society·William H ShrankJerry Avorn
Dec 22, 2005·Clinical Therapeutics·Robert J Gilkin
Feb 10, 2007·Psychosomatic Medicine·Gregory S SayukRay E Clouse

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

The New England Journal of Medicine
Howard R Mertz
Neurogastroenterology and Motility : the Official Journal of the European Gastrointestinal Motility Society
S M PatelA J Lembo
© 2021 Meta ULC. All rights reserved